Evidence map›Paper›PMID 34702338›Full record

ArticleSubstance abuse treatment, prevention, and policy2021

Perceived healthcare stigma among patients in opioid substitution treatment: a qualitative study.

Lars Garpenhag, Disa Dahlman

Open access · goldAbstract read
In one paragraph

Article in Substance abuse treatment, prevention, and policy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The Socioeconomic Impact of Long-Acting Injectable Buprenorphine.ClinicoEconomics and outcomes research : CEOR · 2026
    Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Emergency department staff compassion is associated with lower fear of enacted stigma among patients with opioid use disorder.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2024
    Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Lars GarpenhagCenter for Primary Health Care Research, Department of Clinical Sciences, Malmö, Lund University/Region Skåne, Sweden, Box, 503 22, Malmö, Sweden.
Disa DahlmanCenter for Primary Health Care Research, Department of Clinical Sciences, Malmö, Lund University/Region Skåne, Sweden, Box, 503 22, Malmö, Sweden. disa.dahlman@med.lu.se.ORCID 0000-0003-0507-8758
Lund University · SEMalmö University · SE

Funding

Lunds Universitet ALF Yngre forskareRegion Skåne Primary Healthcare Management funding
6 · The paper itself

Abstract

backgroundPeople with substance use disorders (SUD) including patients in opioid substitution treatment (OST) are subject to stigma, and have generally poor health and barriers towards seeking healthcare. Experience of stigma might negatively affect healthcare seeking, but this topic is sparsely investigated. The aim of this study was to explore OST patients' past and present experiences of substance use stigma in healthcare settings, in order to provide insight into the challenges that people with opioid use disorder may face when using health services, and the strategies they use to cope with them.

methodsSix focus groups with 23 OST patients were moderated by OST staff, and conducted with a questioning route focusing on health literacy. Experiences associated with stigma and its consequences that were spontaneously brought up by participants were assessed in a secondary analysis using a thematic approach.

resultsExperiences of stigma from a wide range of healthcare settings were reported. Medical records and patients' oral information regarding substance use, OST medication or hepatitis C infection were identified as circumstances bringing unwanted attention to the SUD. Participants reported various forms of poor treatment, believed to reflect views of people with SUD as morally culpable, intimidating, curious, untrustworthy and less valuable than other patients, sometimes with tangible effects on the quality of healthcare. Stigma in healthcare settings affected healthcare seeking behaviors, and could result in patients concealing their OST status or substance use history.

conclusionThis study highlights several aspects of perceived healthcare stigma that can shed light on difficulties that OST patients might experience when navigating the healthcare system. The results implicate a need to investigate attitudes towards OST patients, and the aptitude to deal with patients with SUD, among healthcare professionals, as well as a need for interventions addressing knowledge deficits and issues tied to values and patient reception among healthcare staff.

Indexed as

Analgesics, OpioidOpioid-Related DisordersHumansOpiate Substitution TreatmentPatient Acceptance of Health CareQualitative ResearchSocial StigmaAnalgesics, OpioidDrug useHealthcare disparitiesOpioid substitution treatmentStigmaSweden

Identifiers

PMID34702338
PMCPMC8549326
OpenAlexW3209194901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.